Taken together, based on previous studies, we determined the clinical significance of GINS2 in NSCLC and demonstrated that GINS2 knockout significantly impaired the proliferation and tumorigenicity of A549 cells. The gene discussed is GINS2; the disease is non-small cell lung carcinoma.